Cytosorbents Corp
CTSO
37 hedge funds and large institutions have $11.1M invested in Cytosorbents Corp in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
27% more capital invested
Capital invested by funds: $8.69M → $11.1M (+$2.37M)
3.35% more ownership
Funds ownership: 6.26% → 9.62% (+3.4%)
3% less funds holding
Funds holding: 38 → 37 (-1)
54% less call options, than puts
Call options by funds: $112K | Put options by funds: $244K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.64M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.23M |
| 3 |
Millennium Management
New York
|
+$895K |
| 4 |
BlackRock
New York
|
+$664K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$587K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$224K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$94K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$70.8K |
| 4 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
-$67.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$50.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
26
IFP Advisors
Tampa,
Florida
| $25K | – | – | – |
|
27
Morgan Stanley
New York
| $23K | +$22.8K | +4,088 | +355% |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| $19K | +$7.82K | +1,400 | +48% |
|
|
AIM
29
Acrospire Investment Management
Chicago,
Illinois
| $16K | -$15.3K | -2,732 | -44% |
|
30
Barclays
London,
United Kingdom
| $11K | +$14K | +2,507 | +5,014% |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $8K | -$2.15K | -384 | -18% |
|
32
JP Morgan Chase
New York
| $7K | -$2.13K | -381 | -19% |
|
33
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | +$3.91K | +699 | New |
|
|
34
Simplex Trading
Chicago,
Illinois
| $1K | -$50.6K | -9,062 | -98% |
|
|
VKH
35
Virtu KCG Holdings
New York
| – | -$94K | -17,268 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$21.3K | -3,806 | -98% |
|
37
Wells Fargo
San Francisco,
California
| – | -$8K | -1,500 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$7.49K | -1,340 | -93% |
|
39
Bank of America
Charlotte,
North Carolina
| – | +$251 | +45 | New |
|
CTSO Hedge Fund Activity: Q1 2017 in Review
37 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2017, worth a combined $11.1M — up 27% from $8.69M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CTSO positions and 2 closed out — a net gain of 4 holders — while 15 added to existing stakes and 11 trimmed.
The largest buyer was Skylands Capital, adding an estimated $1.64M. The largest seller was Raymond James & Associates, cutting an estimated $224K.
- 37 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2017, down from 38 in Q4 2016.
- Funds reported $11.1M of Cytosorbents Corp stock for Q1 2017, up 27% quarter-over-quarter.
- 6 funds opened new Cytosorbents Corp positions in Q1 2017 and 2 closed out, a net change of +4 holders.
- The largest Cytosorbents Corp buyer in Q1 2017 was Skylands Capital, an estimated $1.64M added.
- The largest Cytosorbents Corp seller in Q1 2017 was Raymond James & Associates, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2017.